KMX

CarMax

$54.19

+0.15%
Nov 10, 2026
Bobby Quantitative Model
CarMax Inc. is the largest used-vehicle retailer in the United States, operating a chain of more than 255 retail stores that sell, finance, and service used and new cars, supplemented by a wholesale auction business and extended service plan offerings; used-vehicle sales accounted for roughly 80% of fiscal 2026 revenue and wholesale about 17%, with the company retailing and wholesaling 780,684 and 538,203 vehicles respectively. Despite its scale, CarMax estimates it holds only about 3.6% share of the US market for vehicles zero to 10 years old, positioning it as a dominant but still under-penetrated consolidator in a highly fragmented, deeply cyclical industry. The current investor narrative centers on a turnaround: after a brutal stretch of margin compression and an outright GAAP loss in fiscal Q4 2026 (EPS of -$0.77), the company has posted two consecutive profitable quarters with Q2 fiscal 2027 EPS of $1.16 and 19.5% revenue growth, fueling debate over whether this is durable earnings recovery or a low-quality, credit-driven bounce. Sentiment remains split, with headlines oscillating between "turnaround play" enthusiasm after strong Q2 results and concern over weaker forward guidance, while the stock's 66.7% one-year gain against a 9.6% SPY return has made valuation and sustainability the central questions for investors.

People also watch

Carvana

Carvana

CVNA

Analysis
Penske Automotive Group

Penske Automotive Group

PAG

Analysis
Lithia Motors

Lithia Motors

LAD

Analysis
AutoNation

AutoNation

AN

Analysis
Valvoline

Valvoline

VVV

Analysis

BobbyInvestment Opinion: Should I buy KMX Today?

Rating: Hold. CarMax is a genuine but unproven turnaround trading at roughly 11.9x the $4.31 consensus EPS against a 25.7x trailing multiple, and with seven of eight covering analysts at Hold-equivalent stances (JP Morgan Neutral, Truist Hold, Morgan Stanley Equal Weight, UBS Neutral, Barclays Equal Weight, RBC Sector Perform, BNP Paribas Underperform) and only Baird and a recent B of A upgrade bullish, the consensus itself argues for patience rather than accumulation at $51.48. The core thesis is that two consecutive profitable quarters ($1.31 in Q1 FY27 and $1.16 in Q2 FY27) after a -$0.77 loss in Q4 FY26 mark a real earnings inflection, but the recovery is being purchased with volume and SG&A discipline rather than improving unit economics, so the burden of proof remains with the bulls.

Supporting evidence is mixed but leans constructive on valuation and negative on quality. Revenue grew 19.46% YoY to $7.878 billion in Q2 FY27, the strongest of the last four quarters, and operating income swung from -$249.7 million in Q4 FY26 to $236.3 million (3.00% margin) in Q2 FY27 while SG&A fell to $628.6 million from $691.7 million. Valuation is undemanding on asset and sales metrics — price-to-book of 1.08x versus 3.37x in Q4 FY22, PS of 0.25x versus 2.30x, and EV/EBITDA of 14.93x near the low end of a historical 49x–234x range — and TTM free cash flow of $1.146 billion is positive. But gross margin compressed to 10.15% from 10.88% a year earlier and 11.84% in Q1 FY26, ROE is only 4.20% against 3.02x debt-to-equity, and the $3.28-to-$5.60 EPS estimate range (a 71% spread) shows how little consensus exists on the recovery's magnitude.

Three risks could invalidate the thesis: gross margin continuing to slide toward 9.8% as volume is bought with pricing concessions, interest expense ($31.8 million in Q2 FY27 against $236.3 million of operating income) rising with 73.9% total debt to capitalization, and a used-vehicle pricing downturn forcing the forward EPS consensus toward the $3.28 low end. This Hold would upgrade to Buy if gross margin stabilizes above 10.5% for two consecutive quarters while EPS tracks toward the $4.31 consensus, or downgrade to Sell if gross margin breaks below 9.8% or the stock loses the $49.82–$50.69 support shelf. On balance the stock is fairly valued to modestly undervalued relative to its own history but not versus the quality of current earnings — the low multiple is partly deserved given leverage and a 4.20% ROE.

Sign up to view all

KMX 12-Month Price Forecast

CarMax offers an asymmetric but unproven setup: at $51.48 the stock trades at roughly 11.9x the $4.31 consensus EPS, which would be cheap if achieved, while price-to-book of 1.08x and PS of 0.25x sit near multi-year lows against 3.37x and 2.30x in prior cycles. The recovery is real at the revenue and operating income line — 19.46% YoY growth and a $486 million operating income swing from Q4 FY26 — but it is being financed by SG&A cuts and volume rather than gross margin, which fell to 10.15%. With 3.02x debt-to-equity, 73.9% total debt to capitalization, and a 4.20% ROE, the balance sheet offers little cushion if used-vehicle prices or credit deteriorate. The Hold-dominated analyst consensus and the 11.52% three-month decline with -6.61 points of relative underperformance versus SPY suggest the market has already priced much of the good news from the 66.71% one-year run. I would upgrade to bullish on two consecutive quarters of gross margin at or above 10.5% with EPS tracking toward $5.00, and downgrade to bearish on a gross margin break below 9.8% or a close under the $49.82 support shelf.

Historical Price
Current Price $54.19
Average Target $54.19
High Target $62.32
Low Target $46.06

Wall Street consensus

Coverage is moderate, with 8 analysts contributing estimates. The consensus is decidedly neutral-to-cautious: institutional ratings show a heavy skew toward Hold-equivalent stances, including JP Morgan (Neutral), Truist (Hold), Morgan Stanley (Equal Weight), UBS (Neutral), Barclays (Equal Weight), RBC (Sector Perform), and BNP Paribas (Underperform), with only Baird (Outperform) and a recent B of A upgrade to Buy providing bullish counterweight. The consensus EPS estimate of $4.31 (range $3.28 to $5.60) and revenue estimate of $30.86 billion (range $28.84 billion to $33.53 billion) imply that at $51.48 the stock trades at roughly 11.9x consensus earnings — a multiple that embeds substantial recovery optimism. A specific average price target is not available in the provided data, so implied upside cannot be calculated precisely, but the rating distribution clearly leans neutral rather than bullish.

The target range itself is wide — EPS estimates span $3.28 to $5.60, a 71% spread from low to high — which signals high uncertainty about the pace of the margin recovery. The high end assumes successful execution on used-vehicle volume growth, SG&A leverage, and a normalization of credit losses, while the low end prices in continued gross margin compression (already down from 11.84% to 10.15% year-over-year) and elevated interest costs on 3.02x leverage. The most notable signal is the B of A upgrade from Underperform to Buy on 2026-10-15, a meaningful sentiment shift, though it was followed by JP Morgan maintaining Neutral on 2026-11-04. With a wide dispersion and a Hold-dominated consensus, the setup suggests limited near-term conviction and elevated volatility around earnings, and investors should treat the forward EPS estimate as the single most important variable to monitor.

Drowning in data?

Find the real signal!

Bulls vs Bears: KMX Investment Factors

The bear case currently holds slightly stronger evidence: gross margin compression to 10.15%, 3.02x leverage, a 4.20% ROE, and a 7-of-8 Hold-dominated analyst consensus all argue that the earnings recovery is low-quality and credit-driven rather than structural. The bull case rests on genuine revenue reacceleration (+19.46% YoY), two straight profitable quarters, and a forward PE of ~11.9x that would be cheap if the $4.31 consensus materializes. The single most important tension is whether the forward EPS estimate is achievable — the $3.28-to-$5.60 range (a 71% spread) means the entire thesis hinges on whether SG&A discipline and volume can offset gross margin pressure and interest costs. If margins stabilize near 10% and the consensus is met, the stock is materially undervalued; if gross margin keeps sliding toward 9.8% and credit losses normalize upward, the low multiple is deserved. Until there is evidence of gross margin inflection rather than just volume growth, the risk/reward is balanced but the burden of proof sits with the bulls.

Bullish

  • Revenue reaccelerating at ~19.5% YoY: Fiscal Q2 2027 revenue hit $7.878 billion, up 19.46% from $6.595 billion a year earlier, with used vehicles at $6.311 billion and wholesale at $1.359 billion driving the step-up. The last four quarters ($5.795B, $5.946B, $8.014B, $7.878B) show a clear volume inflection after a prolonged slump.
  • Forward PE of ~11.9x embeds recovery: At $51.48 against the $4.31 consensus EPS, KMX trades at roughly 11.9x forward earnings versus a 25.7x trailing PE, a gap that implies the market is pricing a dramatic earnings recovery. If the consensus is achieved, the stock is cheap on an absolute and historical basis.
  • Two consecutive profitable quarters: After a -$0.77 EPS loss in Q4 FY26, CarMax posted $1.31 in Q1 FY27 and $1.16 in Q2 FY27, with Q2 operating income of $236.3 million (3.00% margin) versus -$249.7 million in Q4 FY26. The swing from a GAAP loss to consistent profitability is the core of the turnaround thesis.
  • Valuation near multi-year lows: Price-to-book of 1.08x is down from 3.37x in Q4 FY22, PS of 0.25x is down from 2.30x, and EV/EBITDA of 14.93x sits near the low end of a historical 49x–234x range. The stock is at the bottom of its own valuation band, which limits further multiple compression if earnings hold.

Bearish

  • Gross margin compressing despite volume: Gross margin fell to 10.15% in Q2 FY27 from 10.88% a year earlier and 11.84% in Q1 FY26, meaning the revenue surge is being bought with pricing and mix concessions rather than operating leverage. Q1 FY27 operating margin was a razor-thin 0.17%, showing how little cushion exists.
  • Heavy leverage with thin coverage: Debt-to-equity is 3.02x, total debt to capitalization is 73.9%, and the equity multiplier is 4.13x, while Q2 interest expense of $31.8 million consumes a meaningful share of $236.3 million operating income. ROE of just 4.20% is weak for the leverage employed, leaving little flexibility if rates or used-vehicle prices move adversely.
  • Hold-dominated analyst consensus: Seven of eight covering analysts sit at Hold-equivalent ratings (JP Morgan Neutral, Truist Hold, Morgan Stanley Equal Weight, UBS Neutral, Barclays Equal Weight, RBC Sector Perform, BNP Paribas Underperform), with only Baird and a recent B of A upgrade bullish. The EPS estimate range of $3.28 to $5.60 is a 71% spread, signaling high uncertainty about the recovery's pace.
  • Lumpy, inventory-driven cash flow: TTM free cash flow of $1.146 billion masks violent quarterly swings: +$1.113 billion in Q3 FY26, -$687.3 million in Q4 FY26, -$85.7 million in Q1 FY27, then +$805.8 million in Q2 FY27. Cash generation is driven by inventory and payables timing rather than durable operating economics.

KMX Technical Analysis

CarMax is in a powerful, sustained uptrend that has recently rolled into a corrective phase. The stock is up 66.71% over the past year versus just 9.59% for SPY, a relative strength advantage of 57.12 percentage points, and remains up 31.03% year-to-date. At the current price of $51.48, the stock sits roughly 80% of the way through its 180-day range, whose low of $36.27 was set on 2026-05-19 and whose high of $64.22 was reached on 2026-08-25 — meaning it is consolidating in the upper portion of its range but has ceded meaningful ground from the peak. That positioning signals residual momentum with growing overextension risk rather than a clean breakout setup.

Short-term momentum has clearly decelerated and now diverges from the longer-term trend. The stock is down 3.38% over the past month and 11.52% over three months, a sharp reversal from the 27.62% six-month gain and 66.71% one-year advance. Notably, the one-month relative strength versus SPY is positive at +1.61 points (SPY fell 4.99% versus KMX's 3.38% decline), but the three-month relative strength is -6.61 points, confirming CarMax has underperformed during the recent leg down. The most recent sessions reinforce the softness: the stock fell 2.13% on the latest day on volume of roughly 1.96 million shares, and the 180-day maximum drawdown of -34.03% underscores how violently this name can retrace even within a broader uptrend.

Key technical levels are well defined. Support sits at the $36.27 52-week low, with an intermediate shelf around $49.82–$50.69 established in mid-October; resistance is the $64.22 high, with the $60–$62 zone acting as the first ceiling after the August peak. A decisive break above $64.22 would confirm trend resumption and likely invite momentum buyers, while a loss of $50 would threaten the medium-term uptrend structure and open the door back toward the $44–$47 area. Volatility is elevated — the -34.03% max drawdown and the 66.71% annual gain imply a high-beta, high-dispersion profile — so position sizing should assume materially wider swings than the broad market, and the current 11.52% three-month pullback should be treated as normal noise within a still-intact longer-term advance rather than a confirmed trend reversal.

Beta

—

—

Max Drawdown

-34.0%

Largest decline past year

52-Week Range

—

Price range past year

Annual Return

+63.0%

Cumulative gain past year

PeriodKMX ReturnS&P 500
1m+3.0%-3.7%
3m-7.7%-2.9%
6m+42.3%+0.2%
1y+63.0%+10.1%
ytd+37.9%+10.0%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

KMX Fundamental Analysis

Revenue is reaccelerating sharply. Fiscal Q2 2027 (quarter ended 2026-08-31) revenue reached $7.878 billion, up 19.46% year-over-year from $6.595 billion in the prior-year quarter, and up sequentially from $8.014 billion in Q1 (a seasonally stronger quarter). The trajectory across the last four quarters — $5.795 billion in Q3 FY26, $5.946 billion in Q4 FY26, $8.014 billion in Q1 FY27, and $7.878 billion in Q2 FY27 — shows a clear step-up in volume, with used vehicles at $6.311 billion and wholesale at $1.359 billion driving the top line. The growth is encouraging, but it is coming alongside gross margin pressure (10.15% in Q2 FY27 versus 10.88% a year earlier), suggesting the company is buying volume with pricing and mix concessions rather than enjoying pure operating leverage.

Profitability is thin and volatile. Q2 FY27 net income was $165.3 million (a 2.10% net margin) on gross profit of $799.5 million (10.15% gross margin), a marked improvement from the Q4 FY26 loss of -$120.7 million (-2.03% net margin) but below the prior-year Q2 net income of $95.4 million on a much smaller revenue base. The critical issue is operating income: Q2 FY27 operating income of $236.3 million (3.00% operating margin) is a genuine recovery from -$249.7 million in Q4 FY26 and -$117.8 million in Q2 FY26, but the trailing operating margin in the valuation data is still -1.58%, and the Q1 FY27 operating margin was a razor-thin 0.17%. Gross margins have compressed from 11.84% in Q1 FY26 to 9.80% in Q1 FY27 and 10.15% in Q2 FY27, so the earnings recovery is being driven more by SG&A discipline ($628.6 million in Q2 FY27 versus $691.7 million in Q4 FY26) and volume than by unit economics.

The balance sheet is the key risk. Debt-to-equity stands at 3.02x, total debt to capitalization is 73.9%, and the company equity multiplier is 4.13x — leverage typical of a captive-finance-heavy retailer but still a constraint on flexibility. Liquidity is adequate with a current ratio of 2.20x, though the quick ratio of 0.57x reflects inventory-heavy working capital. Free cash flow is lumpy: $1.146 billion TTM, but quarterly FCF swung from +$1.113 billion in Q3 FY26 to -$687.3 million in Q4 FY26 to -$85.7 million in Q1 FY27 and back to +$805.8 million in Q2 FY27, driven largely by inventory and payables timing. ROE of 4.20% is weak for the leverage employed, and with interest expense of $31.8 million in Q2 FY27 against $236.3 million of operating income, coverage is thin — the company can fund itself internally in good quarters but remains sensitive to rates and used-vehicle pricing.

Quarterly Revenue

$7.9B

2026-08

Revenue YoY Growth

+19.5%

YoY Comparison

Gross Margin

10.2%

Latest Quarter

Free Cash Flow

$1.1B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Used Vehicles
Wholesale Vehicles

Open an Account, get $2 TSLA now!

Valuation Analysis: Is KMX Overvalued?

Because net income is positive on a trailing basis (EPS of $0.04 and trailing net income positive), the PE ratio is the appropriate primary metric, and it tells a complicated story. The trailing PE is 25.70x, but the forward PE derived from the analyst EPS estimate of $4.31 is roughly 11.9x at the $51.48 price — an enormous gap that implies the market expects a dramatic earnings recovery from the current depressed base. That gap is the entire investment debate: if the $4.31 consensus is achieved, the stock is cheap; if it is not, the trailing multiple is not obviously supportive. Note that the reported forward PE of -0.54x in the data appears to be a PEG-derived artifact and should be disregarded in favor of the estimate-based calculation.

On peer-relative metrics, CarMax screens cheap. Its PS ratio of 0.25x and price-to-book of 1.08x are low in absolute terms, and its EV/EBITDA of 14.93x is elevated only because EBITDA is depressed — the historical enterprise value multiple has ranged from 49x to 234x over the past several years, so the current 14.93x is actually near the low end of its own history. Against a consumer-cyclical auto dealership peer set, a 0.25x PS multiple reflects the low-margin, high-turnover nature of the business (10.84% gross margin, 0.96% net margin) rather than a clear discount; the premium or discount versus peers is difficult to establish precisely from the provided data, but the combination of a sub-1.1x book multiple and a low-teens forward earnings multiple suggests the market is pricing meaningful execution risk.

Historically, CarMax's valuation has compressed dramatically. Its PE ratio was 61.7x in Q4 FY24, 35.8x in Q4 FY25, and 25.7x today, while price-to-book has fallen from 3.37x in Q4 FY22 to 1.08x now and PS from 2.30x to 0.25x. The stock is therefore near the bottom of its own multi-year valuation band on book and sales, which can signal either a value opportunity or fundamental deterioration — and given the margin compression and leverage, the market is currently leaning toward the latter. The bull case requires the forward EPS estimate to materialize; the bear case is that the low multiple is deserved given 3.02x debt-to-equity and a 4.20% ROE.

PE

25.7x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 9x~39x

vs. Industry Avg

15.6x

Industry PE ~15.6x*

EV/EBITDA

14.9x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks are substantial and quantifiable. Debt-to-equity of 3.02x and total debt to capitalization of 73.9% leave the balance sheet sensitive to rates, with Q2 FY27 interest expense of $31.8 million against $236.3 million of operating income — thin coverage for a business with a 10.15% gross margin. Gross margin has compressed from 11.84% in Q1 FY26 to 9.80% in Q1 FY27 and 10.15% in Q2 FY27, so the recovery depends on SG&A discipline ($628.6 million in Q2 FY27 versus $691.7 million in Q4 FY26) and volume rather than unit economics. Free cash flow is lumpy, swinging from +$1.113 billion in Q3 FY26 to -$687.3 million in Q4 FY26, and ROE of 4.20% is weak for the leverage employed, meaning the company has limited room to absorb a used-vehicle pricing downturn.

Market and competitive risks center on valuation and cyclicality. The stock trades at 25.7x trailing earnings but only ~11.9x the $4.31 forward consensus, so any shortfall in the recovery path would leave the trailing multiple looking unsupported; the EPS estimate range of $3.28 to $5.60 (a 71% spread) confirms how wide the outcome distribution is. The 66.71% one-year gain versus 9.59% for SPY and a 57.12-point relative strength advantage mean the stock has already priced in a lot of good news, and the 11.52% three-month decline with -6.61 points of relative underperformance shows momentum is fading. Competitive pressure from Carvana and other digital used-car platforms, plus a credit-sensitive customer base that is disproportionately hurt by high interest rates (as highlighted in recent Carvana coverage), adds a structural threat to CarMax's volume-led strategy.

In a worst-case scenario, a used-vehicle pricing downturn combines with continued gross margin compression toward 9.8% and rising credit losses, forcing the forward EPS consensus of $4.31 to reset toward the $3.28 low end. At that point the forward multiple would expand to roughly 15.7x on depressed earnings, and the stock could retrace to its 52-week low of $36.27 — a decline of about 29.5% from the current $51.48. The 180-day maximum drawdown of -34.03% shows this magnitude of loss is not hypothetical but has already occurred once within the past year, and a break below the $49.82–$50.69 support shelf would open the door toward the $44–$47 area as an intermediate downside target.

FAQ

Ranked by severity: first, margin and earnings-quality risk — gross margin compressed to 10.15% in Q2 FY27 from 10.88% a year earlier and 11.84% in Q1 FY26, and Q1 FY27 operating margin was just 0.17%, so the recovery rests on SG&A cuts ($628.6 million versus $691.7 million in Q4 FY26) and volume rather than unit economics. Second, balance-sheet and rate risk — debt-to-equity of 3.02x, total debt to capitalization of 73.9%, and $31.8 million of Q2 interest expense against $236.3 million of operating income leave thin coverage, and the credit-sensitive used-car customer base is disproportionately hurt by high rates, as Carvana's pressure illustrates. Third, cyclical and competitive risk — a used-vehicle pricing downturn would hit wholesale and retail GPU simultaneously while digital competitors pressure volumes, and the 71% EPS estimate spread ($3.28 to $5.60) shows how wide the outcome distribution is. Fourth, momentum and valuation risk — the stock is down 11.52% over three months with -6.61 points of relative underperformance versus SPY after a 66.71% one-year run, and the 180-day max drawdown of -34.03% shows how violently it can retrace; a break below the $49.82-$50.69 shelf would target $44-$47 and then the $36.27 low.

The base case carries 50% probability with a $52-$60 target range, assuming EPS lands near the $4.31 consensus, revenue near $30.86 billion, gross margin holds in the 9.8%-10.5% band, and interest expense stays near $32 million per quarter — the stock grinds higher but the Hold consensus and 3.02x leverage cap multiple expansion. The bull case at 25% probability targets $64.22-$72.00, requiring gross margin at or above 10.5%, SG&A below $650 million per quarter, EPS tracking toward the $5.60 high estimate, and further upgrades after B of A's move to Buy on 2026-10-15. The bear case at 25% probability targets $36.27-$44.00, driven by a used-vehicle pricing downturn, margin sliding toward 9.8%, rising credit losses, and consensus EPS resetting toward $3.28. The base case is most likely because it requires only that current trends persist rather than improve, but the single key assumption is gross margin stabilization — if that fails, the distribution shifts decisively toward the bear case.

The answer depends entirely on which earnings number you trust. On trailing figures the stock is not cheap at 25.70x earnings with a 0.96% net margin and a -1.58% trailing operating margin, but on the $4.31 forward consensus it trades at roughly 11.9x, which would be inexpensive for a business growing revenue 19.46% YoY. Asset and sales multiples sit at the bottom of the company's own historical band: price-to-book of 1.08x versus 3.37x in Q4 FY22, PS of 0.25x versus 2.30x, and EV/EBITDA of 14.93x versus a historical 49x-234x range (elevated then because EBITDA was depressed). The market is therefore pricing meaningful execution risk rather than a clear discount — the low multiple is partly deserved given 3.02x leverage and a 4.20% ROE. If the consensus is met, the stock is undervalued; if EPS resets toward $3.28, the forward multiple expands to about 15.7x on depressed earnings and the current price looks fair to full. Note the reported forward PE of -0.54x is a PEG-derived artifact and should be disregarded.

The risk/reward is balanced rather than compelling at $51.48. On the positive side, KMX trades at roughly 11.9x the $4.31 consensus EPS versus a 25.7x trailing multiple, price-to-book of 1.08x is near multi-year lows, and revenue grew 19.46% YoY to $7.878 billion in Q2 FY27 with operating income swinging from -$249.7 million in Q4 FY26 to $236.3 million. On the negative side, gross margin fell to 10.15% from 10.88% a year earlier and 11.84% in Q1 FY26, debt-to-equity is 3.02x, ROE is only 4.20%, and seven of eight analysts sit at Hold-equivalent ratings with no published average target to anchor upside. The biggest downside risk is a margin break toward 9.8% combined with an EPS reset toward the $3.28 low estimate, which could take the stock to the $36.27 52-week low, about -29.5%. It is a reasonable buy only for investors with a 12-24 month horizon who size positions for a 34% drawdown and want to wait for confirmation of gross margin at or above 10.5% for two consecutive quarters; for everyone else, the Hold-dominated consensus and 71% EPS estimate spread argue for patience.

This is primarily a medium-to-long-term holding rather than a trading vehicle. The company is in a mid-stage cyclical recovery with two profitable quarters behind it, no dividend (0% yield, 0% payout), and earnings visibility that is genuinely poor — the analyst EPS range of $3.28 to $5.60 is a 71% spread, which is far too wide to support short-term conviction trades around catalysts. Volatility is elevated: the 180-day max drawdown is -34.03%, the stock is up 66.71% over one year versus 9.59% for SPY, and it has already given back 11.52% over three months, so short-term positioning requires wide stops around the $49.82-$50.69 support shelf. A concrete minimum holding period of 12-24 months is appropriate, long enough to observe at least four to six quarters of gross margin and credit-loss data and to let the $4.31 consensus either validate or reset. Long-term investors should also monitor the 3.02x leverage and 4.20% ROE, since a captive-finance-heavy retailer with thin coverage offers limited compounding if used-vehicle prices stay soft.